# PR Review Summary - v1 Hardening

## Scope

This summary packages release-readiness context for review and does not change application behavior.

## 1) Completed Phases

Completed and documented in this branch:

1. Phase 11: server-side bootstrap and staff invite endpoint scaffolding.
2. Phase 12: endpoint hardening scaffolds (audit, idempotency, correlation, rate-limit strategy).
3. Phase 13: additive multi-tenant/super-admin architecture draft.
4. Phase 14: helper-only multi-scope RLS draft and mapping runbook.
5. Phase 15: shadow validation matrix and SQL validation script.
6. Phase 16: staging evidence runbook and execution report template.
7. Phase 17: pending execution report with provisional no-go.
8. Phase 18: local readiness artifacts for fast staging execution.
9. Phase 19: PR readiness and security review package.

## 2) What Changed

1. New backend API scaffolds for bootstrap and staff invitation (server-side path).
2. Shared backend safety utilities for request validation, correlation, idempotency, and audit handling.
3. Additive draft schema and helper-function documentation for future multi-scope authorization.
4. Full QA and security documentation package for staging shadow validation and release gates.

## 3) What Did Not Change

1. No clinical page behavior change in this phase set.
2. No intentional update to store/clinical.js for these release phases.
3. No active RLS cutover was applied.
4. No patient or clinical policy replacement occurred.
5. No production deployment or production migration apply was performed.

## 4) What Remains Behind Feature Flags

1. Supabase-auth transition paths remain feature-flag controlled.
2. Default auth behavior remains unchanged (Supabase Auth not forced on by default).
3. Migration-era compatibility paths remain active for transitional operation.

## 5) What Is Documentation-Only

Phases 15 through 19 are primarily readiness, validation, and governance packaging:

1. Shadow validation plan and matrices.
2. Execution runbook and report templates.
3. Staging access and fixture checklists.
4. Merge gates and blocker tracking.

## 6) What Requires Staging Access

1. Execution of helper shadow SQL validation with real fixture UUIDs.
2. Evidence capture for cross-tenant denials, break-glass checks, and compatibility checks.
3. Reviewer signoff on real pass/fail outputs.
4. Final go/no-go decision backed by actual staging evidence.

## 7) Why Phase 17 Remains Pending/No-Go

1. Staging project access is not available in current workspace/session context.
2. Staging credentials and SQL console access are missing.
3. Fixture UUID map is missing.
4. Staging-only migration status confirmation is missing.

No validation results were fabricated.

## 8) Why Production Deploy/Merge Should Wait

1. Merge gates require real staging evidence from Phase 17 execution.
2. Cross-tenant denial checks must pass on real staging fixtures.
3. Break-glass eligibility checks must be validated with real platform role fixtures.
4. Reviewer and security signoff are still pending.
5. Current status remains provisional no-go until blockers are closed.

## 9) Review Outcome Target

Target outcome for this PR stage:

1. Accept documentation and readiness package.
2. Keep release status as blocked pending staging execution evidence.
3. Do not treat readiness artifacts as proof of staging validation pass.
